Specialty Pharma Journal Specialty, Precision & Technology
4 MAY 2017 | GENEVA – This year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries. In September, WHO will invite manufacturers to submit applications for prequalification of …
Tag Archives: WHO
May, 2017
February, 2016
-
10 February
Hemispherx Biopharma Exploring Possible Research Programs in Zika Virus
Philadelphia, PA, Tuesday, February 09, 2016: Hemispherx Biopharma, Inc. (NYSE MKT: HEB) announced today that it is beginning to consider study designs for potential tests of the activity and potential uses of its natural alpha interferon (Alferon® N and Alferon® LDO) and rintatolimod (Ampligen®) drug formulations against the Zika virus. The …
January, 2016
-
15 January
Boehringer Ingelheim Inks $262 Million CNS Deal with Arena Pharmaceuticals
INGELHEIM, Germany, and SAN DIEGO, Jan. 12, 2016 /PRNewswire/ — Boehringer Ingelheim and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that they have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undisclosed G protein-coupled receptor (GPCR), which belongs to the group of orphan CNS …
May, 2015
-
8 May
WHO Adds New Hep C Drugs to Essential List but Lower Prices are Needed for Patient Access
Today, the World Health Organization (WHO) updated its list of essential drugs, adding new key hepatitis C drugs, but said that prices need to be reduced in order to be accessible to patients in poorer countries. The agency added to the list of essential drugs five new direct acting oral …